SB
BIIB icon

Suntrust Banks’s Biogen BIIB Stock Holding History

Suntrust Banks’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$8.8M Buy
37,799
+1,347
+4% +$314K 0.05% 267
2019
Q2 		$8.53M Sell
36,452
-2,358
-6% -$544K 0.04% 267
2019
Q1 		$9.17M Buy
38,810
+2,628
+7% +$828K 0.05% 244
2018
Q4 		$10.9M Buy
36,182
+8,830
+32% +$2.82M 0.06% 215
2018
Q3 		$9.66M Buy
27,352
+2,768
+11% +$953K 0.05% 241
2018
Q2 		$7.13M Buy
24,584
+6,249
+34% +$1.76M 0.04% 270
2018
Q1 		$5.02M Buy
18,335
+8,063
+78% +$2.5M 0.03% 307
2017
Q4 		$3.27M Sell
10,272
-7,283
-41% -$2.34M 0.02% 369
2017
Q3 		$5.5M Buy
17,555
+801
+5% +$237K 0.03% 288
2017
Q2 		$4.55M Sell
16,754
-6,399
-28% -$1.69M 0.03% 309
2017
Q1 		$6.33M Sell
23,153
-3,060
-12% -$865K 0.04% 247
2016
Q4 		$7.43M Buy
26,213
+8,341
+47% +$2.47M 0.04% 240
2016
Q3 		$5.59M Sell
17,872
-2,684
-13% -$795K 0.03% 274
2016
Q2 		$4.97M Sell
20,556
-793
-4% -$209K 0.03% 283
2016
Q1 		$5.55M Sell
21,349
-304
-1% -$80.3K 0.03% 255
2015
Q4 		$6.63M Buy
21,653
+213
+1% +$61.2K 0.04% 232
2015
Q3 		$6.26M Sell
21,440
-22,812
-52% -$7.53M 0.04% 231
2015
Q2 		$17.9M Sell
44,252
-3,398
-7% -$1.36M 0.12% 143
2015
Q1 		$20.1M Buy
47,650
+2,287
+5% +$901K 0.13% 132
2014
Q4 		$15.4M Sell
45,363
-16,775
-27% -$5.43M 0.1% 146
2014
Q3 		$20.6M Buy
62,138
+24,659
+66% +$8.13M 0.14% 119
2014
Q2 		$11.8M Sell
37,479
-115,076
-75% -$34.6M 0.08% 172
2014
Q1 		$46.7M Sell
152,555
-78,564
-34% -$24.9M 0.17% 187
2013
Q4 		$64.6M Sell
231,119
-5,904
-2% -$1.53M 0.25% 129
2013
Q3 		$57.1M Sell
237,023
-31,984
-12% -$7.16M 0.22% 137
2013
Q2 		$57.9M Buy
+269,007
New +$57.5M 0.26% 118

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Suntrust Banks's BIIB Position: Q3 2019 in Review

Suntrust Banks increased its Biogen (BIIB) stake by 3.7% in Q3 2019, buying an estimated $314K and bringing the position to 37,799 shares worth $8.8M. The position accounts for 0.05% of the portfolio, ranked #267.

Suntrust Banks first reported a position in BIIB in Q2 2013 and has held it in 26 quarters since. The position peaked at $64.6M in Q4 2013. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Suntrust Banks held 37,799 shares of Biogen worth $8.8M as of Q3 2019.
  • Suntrust Banks bought 1,347 Biogen shares in Q3 2019, an estimated $314K.
  • Biogen made up 0.05% of Suntrust Banks's portfolio in Q3 2019, its #267 holding.
  • Suntrust Banks first reported a position in Biogen in Q2 2013 and has held it in 26 quarters since.
  • Suntrust Banks's Biogen position peaked at $64.6M in Q4 2013.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.